The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Despite revenue growth, net income for Q3 2024 shows a significant decrease compared to the previous year, highlighting potential areas for strategic improvement. CVS Health Corp's recent acquisitions ...

The claims processor may charge a second fee for the accurate submission by the pharmacy. The PBM is the entity for which the entire prescription claims industry has been named. PBMs interface ...

With the launch of its pharmacy network technology, prescription management has gotten a lot more streamlined and seamless for their healthcare providers. Addressing Industry Fragmentation ... forward ...

The integration of AI into drug submission and approval processes signifies a shift towards more efficient pharmaceutical development. The potential benefits are substantial, including faster ...

HDS, a leading provider of pharmacy payment integrity and analytics solutions for healthcare payers, self-funded employers, and specialty pharmacies today announced its Spotlight platform has earned ...

New Delhi: Pharmaceutical major Pfizer has received the go-ahead from the Subject Expert Committee (SEC), which is functional ...

Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

Focus on Health and Wellness: With a heightened focus on health and wellness, consumers are turning to dietary supplements to ...

Rodica Ceslov explores the challenges associated with social media in the pharmaceutical industry and the benefits of pushing ... publishing, management consulting, non profit, retail, food ...

Third Quarter Total Net Product Sales of $28.7 MillionRolvedon Net Product Sales of $15.0 Million Cash and Short-Term Investments of $88.6 ...